CRISPR/Cas9 technology has been developing rapidly in the field of parasitology, allowing for the dissection of molecular processes with unprecedented efficiency. Optimization and implementation of a new technology like CRISPR, especially in nonmodel organisms, requires communication and collaboration throughout the field. Recently, a 'CRISPR in Parasitology' symposium was held at the Institut Pasteur Paris, bringing together scientists studying Leishmania, Plasmodium, Trypanosoma, and Anopheles. Here we share technological advances and challenges in using CRISPR/Cas9 in the parasite and vector systems that were discussed. As CRISPR/Cas9 continues to be applied to diverse parasite systems, the community should now focus on improvement and standardization of the technique as well as expanding the CRISPR toolkit to include Cas9 alternatives/derivatives for more advanced applications like genome-wide functional screens.
A CRISPR/Cas9 Revolution in ParasitologyParasitic diseases such as leishmaniasis, malaria, and trypanosomiasis remain an enormous burden on human health around the globe. While the genomes of Leishmania, Plasmodium, Trypanosoma, and Anopheles were first sequenced over a decade ago, the study of gene function has been slowed by tedious or inadequate genome-editing techniques [1][2][3][4]. Thus, the first studies using CRISPR/Cas9 (see Glossary) gene editing in eukaryotes provided exciting new possibilities in the field of parasitology [5][6][7]. This simple, yet efficient system of genome editing uses the Cas9 endonuclease to generate a double-strand break (DSB) at a locus of interest in the genome (Figure 1A , Key Figure ). Specificity is achieved via Cas9 binding to a single guide RNA (sgRNA), which must contain 20 nucleotides complimentary to a sequence in the genome flanking a protospacer-adjacent motif (PAM). The DSB break is then repaired with homology-directed repair (HDR) using a provided repair template or with the more error-prone microhomology-mediated end joining (MMEJ) or nonhomologous end joining (NHEJ) pathways, depending on the organism (Table 1). CRISPR/Cas9 allows for deletion, insertion, or mutation of DNA with little to no genetic scarring. CRISPR/Cas9 technology is revolutionizing parasitology research and gene drive systems in insect vectors; and while this review focuses on Plasmodium, Leishmania, Trypanosoma, and Anopheles, CRISPR/Cas9 has been successfully adapted to many more parasite systems, including Toxoplasma [8], Cryptosporidium [9], Strongyloides [10], and Trichomonas vaginalis [11]. As CRISPR/Cas9-based technology evolves, the parasitology community is quickly discovering methods that work well, techniques that can be improved, and ongoing challenges Highlights CRISPR/Cas9 genome editing technology has greatly advanced functional studies in parasites such as Leishmania, Plasmodium, and Trypanosoma, and insect vectors, including Anopheles.